Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 505

1.

[Confirmed Dengue, Chikungunya and Zika Cases during the Period 2014 to 2016 in Barcelona, Spain].

González R, Camprubí E, Fernández L, Millet JP, Peracho V, Gorrindo P, Avellanés I, Romero A, Caylà JA.

Rev Esp Salud Publica. 2017 Mar 7;91. pii: e201701027. Spanish.

2.

Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial.

Ruhwald M, Aggerbeck H, Gallardo RV, Hoff ST, Villate JI, Borregaard B, Martinez JA, Kromann I, Penas A, Anibarro LL, de Souza-Galvão ML, Sánchez F, Rodrigo-Pendás JÁ, Noguera-Julian A, Martínez-Lacasa X, Tuñez MV, Fernández VL, Millet JP, Moreno A, Cobos N, Miró JM, Roldan L, Orcau A, Andersen P, Caylá JA; TESEC Working Group..

Lancet Respir Med. 2017 Jan 31. pii: S2213-2600(16)30436-2. doi: 10.1016/S2213-2600(16)30436-2. [Epub ahead of print]

PMID:
28159608
3.

Retrospective study of clinical and lesion characteristics of patients undergoing surgical treatment for Pulmonary Tuberculosis in Georgia.

Vashakidze S, Despuig A, Gogishvili S, Nikolaishvili K, Shubladze N, Avaliani Z, Tukvadze N, Casals M, Caylà JA, Cardona PJ, Vilaplana C.

Int J Infect Dis. 2017 Mar;56:200-207. doi: 10.1016/j.ijid.2016.12.009. Review.

4.

Tuberculosis clinical units improve contact tracing.

Brugueras S, Orcau À, Millet JP, Espinosa L, de Andrés A, Gorrindo P, Caylà JA.

Int J Tuberc Lung Dis. 2016 Dec 1;20(12):1572-1579. doi: 10.5588/ijtld.16.0147.

PMID:
28000581
5.

The effects of aminosalicylates or thiopurines on the risk of colorectal cancer in inflammatory bowel disease.

Carrat F, Seksik P, Colombel JF, Peyrin-Biroulet L, Beaugerie L; CESAME Study Group..

Aliment Pharmacol Ther. 2017 Feb;45(4):533-541. doi: 10.1111/apt.13897.

PMID:
27995656
6.

Factors influencing the spread of pertussis in households: a prospective study, Catalonia and Navarre, Spain, 2012 to 2013.

Godoy P, García-Cenoz M, Toledo D, Carmona G, Caylà JA, Alsedà M, Àlvarez J, Barrabeig I, Camps N, Plans P, Company M, Castilla J, Sala-Farré MR, Muñoz-Almagro C, Rius C, Domínguez À; Transmission of Pertussis in Households Working Group..

Euro Surveill. 2016 Nov 10;21(45). pii: 30393. doi: 10.2807/1560-7917.ES.2016.21.45.30393.

7.

Epidemiology of pertussis in two Ibero-American countries with different vaccination policies: lessons derived from different surveillance systems.

Solano R, Masa-Calles J, Garib Z, Grullón P, Santiago SL, Brache A, Domínguez Á, Caylà JA.

BMC Public Health. 2016 Nov 22;16(1):1178.

8.

Underdetection and underreporting of pertussis in children attended in primary health care centers: Do surveillance systems require improvement?

Solano R, Crespo I, Fernández MI, Valero C, Álvarez MI, Godoy P, Caylà JA, Domínguez À.

Am J Infect Control. 2016 Nov 1;44(11):e251-e256. doi: 10.1016/j.ajic.2016.03.033.

PMID:
27184210
9.

Acute Morphine Exposure Increases the Brain Distribution of [18F]DPA-714, a PET Biomarker of Glial Activation in Nonhuman Primates.

Auvity S, Saba W, Goutal S, Leroy C, Buvat I, Cayla J, Caillé F, Bottlaender M, Cisternino S, Tournier N.

Int J Neuropsychopharmacol. 2016 Oct 19. pii: pyw077. doi: 10.1093/ijnp/pyw077. [Epub ahead of print]

PMID:
27581167
10.

Epidemiology of Tuberculosis in Immigrants in a Large City with Large-Scale Immigration (1991-2013).

Ospina JE, Orcau À, Millet JP, Ros M, Gil S, Caylà JA; Barcelona Tuberculosis Immigration Working Group..

PLoS One. 2016 Oct 17;11(10):e0164736. doi: 10.1371/journal.pone.0164736.

11.

Factors associated with smoking among tuberculosis patients in Spain.

Jiménez-Fuentes MÁ, Rodrigo T, Altet MN, Jiménez-Ruiz CA, Casals M, Penas A, Mir I, Solano Reina S, Riesco-Miranda JA, Caylá JA; Smoking and Tuberculosis Research Working Group..

BMC Infect Dis. 2016 Sep 14;16:486. doi: 10.1186/s12879-016-1819-1.

12.

Factors Associated with Fatality during the Intensive Phase of Anti-Tuberculosis Treatment.

Rodrigo T, Casals M, Caminero JA, García-García JM, Jiménez-Fuentes MA, Medina JF, Millet JP, Ruiz-Manzano J, Caylá J; Working Group of the Integrated Programme of Tuberculosis Research..

PLoS One. 2016 Aug 3;11(8):e0159925. doi: 10.1371/journal.pone.0159925.

13.

[Zika virus infection: a new public health emergency with great media impact].

Caylà JA, Domínguez Á, Rodríguez Valín E, de Ory F, Vázquez A, Fortuny C; Grupo de trabajo sobre Zika del Programa de Prevención, Vigilancia y Control de Enfermedades Transmisibles (PREVICET) del CIBER de Epidemiología y Salud Pública (CIBERESP)..

Gac Sanit. 2016 Nov - Dec;30(6):468-471. doi: 10.1016/j.gaceta.2016.05.015. Spanish.

14.

COBA-Cohort: a prospective cohort of HIV-negative men who have sex with men, attending community-based HIV testing services in five European countries (a study protocol).

Lorente N, Fernàndez-López L, Fuertes R, Rojas Castro D, Pichon F, Cigan B, Chanos S, Meireles P, Lucas R, Morel S, Slaaen Kaye P, Agustí C, Klavs I, Platteau T, Casabona J; Euro HIV EDAT Study Group..

BMJ Open. 2016 Jul 13;6(7):e011314. doi: 10.1136/bmjopen-2016-011314.

15.

Characterization of unrelated clinical Legionella pneumophila isolates in Catalonia by monoclonal subgrouping and sequence-based typing.

Garcia-Nuñez M, Quero S, Pedro-Botet ML, Barrabeig I, Avarez J, Campoy I, Sala MR, Parraga-Niño N, Minguell S, Caylà J, Mateu L, Sabria M.

Future Microbiol. 2016 Jul;11:865-75. doi: 10.2217/fmb-2016-0013.

PMID:
27357520
16.

Tuberculosis Costs in Spain and Related Factors.

Gullón JA, García-García JM, Villanueva MÁ, Álvarez-Navascues F, Rodrigo T, Casals M, Anibarro L, García-Clemente MM, Jiménez MÁ, Bustamante A, Penas A, Caminero JA, Caylà J; Grupo de Trabajo del Programa Integrado de Investigación en Tuberculosis (PII TB)..

Arch Bronconeumol. 2016 Dec;52(12):583-589. doi: 10.1016/j.arbres.2016.05.002. English, Spanish.

17.

Fixed-dose combinations of drugs versus single-drug formulations for treating pulmonary tuberculosis.

Gallardo CR, Rigau Comas D, Valderrama Rodríguez A, Roqué i Figuls M, Parker LA, Caylà J, Bonfill Cosp X.

Cochrane Database Syst Rev. 2016 May 17;(5):CD009913. doi: 10.1002/14651858.CD009913.pub2. Review.

18.

Restricting Access to Health Care to Immigrants in Barcelona: A Mixed-Methods Study With Immigrants Who Have Experienced an Infectious Disease.

Castano J, Ospina JE, Caylà JA, Greer SL.

Int J Health Serv. 2016;46(2):241-61. doi: 10.1177/0020731416637174.

PMID:
27076652
19.

Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.

Iribarren JA, Rubio R, Aguirrebengoa K, Arribas JR, Baraia-Etxaburu J, Gutiérrez F, Lopez Bernaldo de Quirós JC, Losa JE, Miró JM, Moreno S, Pérez Molina J, Podzamczer D, Pulido F, Riera M, Rivero A, Sanz Moreno J, Amador C, Antela A, Arazo P, Arrizabalaga J, Bachiller P, Barros C, Berenguer J, Caylá J, Domingo P, Estrada V, Knobel H, Locutura J, López Aldeguer J, Llibre JM, Lozano F, Mallolas J, Malmierca E, Miralles C, Miralles P, Muñoz A, Ocampo A, Olalla J, Pérez I, Pérez Elías MJ, Pérez Arellano JL, Portilla J, Ribera E, Rodríguez F, Santín M, Sanz Sanz J, Téllez MJ, Torralba M, Valencia E, Von Wichmann MA; GESIDA/SEIMC Writing Committee..

Enferm Infecc Microbiol Clin. 2016 Oct;34(8):517-23. doi: 10.1016/j.eimc.2016.02.025.

PMID:
27056581
20.

Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.

Iribarren JA, Rubio R, Aguirrebengoa K, Arribas JR, Baraia-Etxaburu J, Gutiérrez F, Lopez Bernaldo de Quirós JC, Losa JE, Miró JM, Moreno S, Pérez Molina J, Podzamczer D, Pulido F, Riera M, Rivero A, Sanz Moreno J, Amador C, Antela A, Arazo P, Arrizabalaga J, Bachiller P, Barros C, Berenguer J, Caylá J, Domingo P, Estrada V, Knobel H, Locutura J, López Aldeguer J, Llibre JM, Lozano F, Mallolas J, Malmierca E, Miralles C, Miralles P, Muñoz A, Ocampo A, Olalla J, Pérez I, Pérez Elías MJ, Pérez Arellano JL, Portilla J, Ribera E, Rodríguez F, Santín M, Sanz Sanz J, Téllez MJ, Torralba M, Valencia E, Von Wichmann MA; GESIDA/SEIMC Writing Committee..

Enferm Infecc Microbiol Clin. 2016 Oct;34(8):516.e1-516.e18. doi: 10.1016/j.eimc.2016.02.004.

PMID:
26976381

Supplemental Content

Loading ...
Support Center